FIELD TRIP HEALTH LTD (FTRP)

CA31656R1029 - Common Stock

0.8421  +0.01 (+1.07%)

After market: 0.8698 +0.03 (+3.29%)

Fundamental Rating

1

FTRP gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 117 industry peers in the Health Care Providers & Services industry. FTRP has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, FTRP is valued expensive at the moment.



Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year FTRP has reported negative net income.
In the past 5 years FTRP always reported negative net income.
In the past 5 years FTRP always reported negative operating cash flow.

1.2 Ratios

Industry RankSector Rank
ROA -53.55%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM -1091.39%
PM (TTM) -1125.3%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

2

2. Health

2.1 Basic Checks

FTRP does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for FTRP has been increased compared to 1 year ago.
FTRP has more shares outstanding than it did 5 years ago.
FTRP has a worse debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of -0.77, we must say that FTRP is in the distress zone and has some risk of bankruptcy.
A Debt/Equity ratio of 0.40 indicates that FTRP is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF N/A
Altman-Z -0.77
ROIC/WACCN/A
WACC8.25%

2.3 Liquidity

A Current Ratio of 8.20 indicates that FTRP has no problem at all paying its short term obligations.
A Quick Ratio of 8.20 indicates that FTRP has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 8.2
Quick Ratio 8.2

More info and screens

4

3. Growth

3.1 Past

The earnings per share for FTRP have decreased strongly by -15.25% in the last year.
FTRP shows a strong growth in Revenue. In the last year, the Revenue has grown by 471.78%.
EPS 1Y (TTM)-15.25%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-38.89%
Revenue 1Y (TTM)471.78%
Revenue growth 3YN/A
Revenue growth 5YN/A
Revenue growth Q2Q225.3%

3.2 Future

Based on estimates for the next years, FTRP will show a small growth in Earnings Per Share. The EPS will grow by 0.94% on average per year.
The Revenue is expected to grow by 99.77% on average over the next years. This is a very strong growth
EPS Next Y-20.59%
EPS Next 2Y-10.54%
EPS Next 3Y-2.39%
EPS Next 5Y0.94%
Revenue Next Year267.08%
Revenue Next 2Y77.85%
Revenue Next 3Y91.55%
Revenue Next 5Y99.77%

3.3 Evolution

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

FTRP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year FTRP is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -0.58

4.3 Compensation for Growth

A cheap valuation may be justified as FTRP's earnings are expected to decrease with -2.39% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-10.54%
EPS Next 3Y-2.39%

More info and screens

0

5. Dividend

5.1 Amount

FTRP does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

FIELD TRIP HEALTH LTD

NASDAQ:FTRP (8/16/2022, 7:00:00 PM)

After market: 0.8698 +0.03 (+3.29%)

0.8421

+0.01 (+1.07%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap48.97M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -53.55%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM -1091.39%
PM (TTM) -1125.3%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 8.2
Quick Ratio 8.2
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-15.25%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-20.59%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)471.78%
Revenue growth 3YN/A
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y